17. The USS report from 18 December says:
‘There is evidence of intra-and extracapsular left implant rupture. There is silicone within the left axillary and supraclavicular lymph nodes.
Right implant appears intact. There is shallow fluid around the medial part of the implant.
No suspicious features.’
18. The consultant reviewed the report from the radiologist. The report found that Mrs T’s implant had ruptured. Based on this report, the consultant told Mrs T her left implant had ruptured and recommended she had the implants removed. They advised that her swollen lymph nodes would only get worse if she did not have them removed.
19. Standard one says:
‘Imaging to check implant integrity Breast implants do not require routine imaging to check the integrity of the implant. If there is clinical concern regarding the integrity, ultrasound should be the first-line tool. If the ultrasound findings are equivocal, or if there is persisting clinical concern, then MRI is indicated.’
20. Our radiology adviser has reviewed all the images and reports. The USS from September and the MRI from October were of Mrs T’s neck. They did not provide any information about her breast implants. They said the USS of Mrs T’s breasts from 18 December 2018 does not show any clear signs that the implant had ruptured.
21. Silicone deposition in the lymph nodes in a woman with breast implants can happen for two reasons, the first being rupture of existing or old implants. Mrs T had a history of implant rupture in the past and silicone in the nodes could have been present since then. Lymph nodes are not routinely taken out when ruptured implants are removed.
22. The second reason is gel bleed. This is when tiny amounts of silicone seep through the undamaged shell. This is due to the semipermeable (material allowing certain substances to pass through it) nature of the implant covering and deposit in the lymph nodes.
23. Radiologists should be aware of gel bleed as implants are not routinely removed because of it. A USS is the first line of investigation when it is suspected an implant has leaked or ruptured. But an MRI of the breast is the most accurate way of assessing the breast implant shell. An MRI should be done unless there is no doubt from a USS that the implant has ruptured.
24. To make sure of fairness and transparency after the Trust commented on the clinical advice we got for this case, we discussed the comments with our radiology adviser two more times. Their advice is unchanged. We are satisfied they have provided advice in line with our clinical standards.
25. Our radiology adviser said there were no definite signs of breast implant rupture in the USS. Mrs T had also had a rupture before, which meant the silicone could have been from then. The Trust radiologist noted the previous rupture in their report, so we are satisfied they were aware of it. In line with standard one, we would have expected the report from the radiologist to recommend Mrs T to have an MRI of her breasts.
26. We know when the private surgeon removed Mrs T’s implant it was intact. Published research (research one and two) show that MRIs are highly accurate when identifying breast implant rupture. We think that had the Trust done an MRI of Mrs T’s breast, it is likely it would have found it was intact.
27. In line with standard one, we consider the Trust did not do the appropriate scans to confirm the diagnosis. The Trust radiologist incorrectly reported on the USS from 18 December 2018. This led to the consultant advising Mrs T that her left breast implant had ruptured.
28. We looked in more detail at the consultation on 18 December as this is when the consultant told Mrs T about the ruptured implant. Standard three says:
‘Clinical assessment History: in women with breast implants symptoms may be incidental or related to the implant, including changes in texture, size or shape; following reconstructive surgery for previous breast cancer there may be concern about recurrence. Record the original reason for the implant (augmentation or reconstruction); the site, i.e. submuscular or subglandular; the nature of any associated reconstructive procedure e.g. latissimus dorsi flap; the date of surgery and type of implant used. If there are symptoms of pain or lump record details as under above protocols.’
29. The clinic letter shows the consultant took an appropriate history, examined Mrs T and recorded the key clinical findings. This is in line with standard three.
30. The consultant confirmed to Mrs T that her left implant had ruptured, but this was based on the report from the radiologist. Breast surgeons work closely with radiologists and rely on their reporting from reviewing the scans.
31. We have not found anything wrong with the consultation on 18 December 2018. The consultant relied on the report from the radiologist and the consultation was in line with standard three.
Impact
32. We considered what impact the failings had on Mrs T. We know Mrs T had private surgery to remove the implant just over a month after the first consultation. We are satisfied that Mrs T would not have had this surgery if the Trust had completed an MRI scan and found the implant was intact.
33. Our Principles of Remedy say organisations should restore complainants to the position they would have been in had the service failure not happened.
34. Mrs T wants reimbursement for the cost of the private surgery and the travel to and from the hospital. The surgery included a breast lift as well as removal of the implants. Mrs T did not have the implants replaced. If Mrs T’s implants were not removed there would have been no need for the breast lift surgery. Both procedures were unnecessary and happened as a direct result of the failing we found.
35. We recognise Mrs T was offered the option of having the implants removed on the NHS and this would have been free. It was Mrs T’s choice to have the operation privately. But Mrs T only made the decision to have this surgery because the consultant had advised her the implant had ruptured and she thought it posed a risk to her health.
36. Mrs T also told us about the emotional impact these events had on her. She says that knowing her health was at risk was extremely distressing and caused her anxiety.
37. We can see from Mrs T’s GP records that she has had depression in the past. Before this matter she was feeling well and was not on any medication. On 6 March 2019, Mrs T had an appointment with her GP about her low mood related to the events of the complaint. Mrs T told her GP she had been unable to get a date for surgery from the Trust. The GP recorded Mrs T’s mood as very low, with occasional suicidal thoughts and she was struggling to sleep. The GP prescribed fluoxetine (an anti-depressant) which she had taken before.
38. We cannot know for sure if there were other factors that contributed to Mrs T’s low mood. We have decided that, on balance, concerns about her health were a large factor in this.
39. These events caused Mrs T a significant level of distress and anxiety which could have been avoided if the Trust had done an MRI scan and found the implant was intact.